🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The LATA trial will find out if taking a long-acting injectable form of HIV...
Status
Unknown
Location
Moi University
Start Date
2023-06-22
Trial ID
NCT05154747
Treatments Being Tested
This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-28
Trial ID
NCT02120352
Treatments Being Tested
GLACIER (Giving Long Acting CABENUVA in an Infusion center/ASA) is an inter...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-11-18
Trial ID
NCT04982445
Treatments Being Tested
This study is designed to assess the antiviral activity and safety of a two...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-11-09
Trial ID
NCT04542070
This study aims to determine whether people living with HIV (PLHIV) with su...
Status
Recruiting
Location
Chang Gung Memorial Hospital, Keelung
Start Date
2024-07-19
Trial ID
NCT06507059
Treatments Being Tested
Context The introduction of the long-acting injectable antiretroviral treat...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05
Trial ID
NCT06403865
Treatments Being Tested
IMPALA is a randomized, open-label, multicenter, interventional study of 54...
Status
Active Not Recruiting
Location
Jaramogi Oginga Odinga Teaching & Referral Hospital
Start Date
2022-12-08
Trial ID
NCT05546242
Treatments Being Tested
This is study seeks to evaluate perspectives of a combined injectable treat...
Status
Withdrawn
Location
Rhode Island Hospital
Start Date
2022-04-01
Trial ID
NCT05991622
Treatments Being Tested
The federal research award entitles "Long-acting injectable antiretroviral ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06704204
The purpose of this study was to determine the dosage for oral cabotegravir...
Status
Completed
Location
Usc La Nichd Crs
Start Date
2019-04-03
Trial ID
NCT03497676